Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
about
Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapyVCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?Significance of gene expression analysis of renal cell carcinoma.Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse.Recent developments in the treatment of renal cell carcinoma.Uncommon and recently described renal carcinomas.Renal Medullary Carcinoma with an Aggressive Clinical Course: A Case Report and Review of the Literature.Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.Renal medullary carcinoma and sickle cell trait: A systematic review.Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature.Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.SMARCB1/INI1 inactivation in renal medullary carcinoma.Lung tumor in a young African American patient with sickle trait: Pieces of a puzzle
P2860
Q34145962-59E5A09C-263B-48AC-BAB4-F3FEA0500F5AQ35155611-5D4640E7-45F2-4059-87E7-27E887E953F5Q36381308-34A253C6-3831-438B-B0E6-26501BEBB351Q37113813-161E5702-6AFA-4703-A2D2-90BC3B2CE5E1Q37300942-CAE6AF57-7004-4CD1-BE5D-69945F921386Q37507517-8BD56CA5-2E1A-4DFA-A441-3B949D164C5EQ37634874-384F0734-49F4-4D9E-BD68-ECDE6662A020Q38421115-325EF957-89E0-4050-AA99-F7775BFD58F8Q38520332-E15BA24E-EA58-4E7E-B41C-4A34E8A0F970Q39176728-7B9A49F1-B2B0-444B-BFC2-F8B3199F8D63Q40396447-A7ED544A-EE46-4519-9CF4-D76FA5BCDB20Q41765743-C24E3895-8EAD-4908-B0BD-6E560D2AEBC0Q41835725-C49AA41A-AF3D-4284-90F4-C21D90A5D6F4Q54305674-75D66267-0C22-46D3-9FB0-05C00D6917BCQ58700953-507D69D9-21B4-4746-A14F-15ADED9DA82B
P2860
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@ast
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@en
type
label
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@ast
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@en
prefLabel
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@ast
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@en
P2093
P2860
P356
P1433
P1476
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
@en
P2093
David J Grignon
Gregory Zagaja
Jun Sugimura
Kyle Furge
Maria S Tretiakova
Michael Pins
Mitchell Sokoloff
Nicholas J Vogelzang
Raymond Bergan
Walter M Stadler
P2860
P304
P356
10.1002/CNCR.20049
P407
P50
P577
2004-03-01T00:00:00Z